Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk

作者：Stefanie Zorn, Rebecca Bounds, Alice Williamson, Katherine Lawler, Ruth Hanßen, Julia M. Keogh, Elana Henning, Miriam Smith, Barbara A. Fielding, A. Margot Umpleby, Summaira Yasmeen, Maria Martí-Solano, Claudia Langenberg, Martin Wabitsch, Tinh‐Hai Collet, I. Sadaf Farooqi · 发表于：Nature Medicine · 年份：2025 · DOI：10.1038/s41591-025-03976-1 · 被引用次数：15 · 研究领域：Regulation of Appetite and Obesity、Biochemical Analysis and Sensing Techniques、Adipokines, Inflammation, and Metabolic Diseases

Obesity causes dyslipidemia and is a major risk factor for cardiovascular disease. However, the mechanisms coupling weight gain and lipid metabolism are poorly understood. Brain melanocortin 4 receptors (MC4Rs) regulate body weight and lipid metabolism in mice, but the relevance of these findings to humans is unclear. Here we investigated lipid levels in men and women with obesity due to MC4R deficiency. Among 7,719 people from the Genetics of Obesity Study cohort, we identified 316 probands and 144 adult family members with loss-of-function (LoF) MC4R mutations. Adults with MC4R deficiency had lower levels of total and low-density lipoprotein (LDL)-cholesterol and triglycerides than 336,728 controls from the UK Biobank, after adjusting for adiposity. Carriers of LoF MC4R variants within the UK Biobank had lower lipid levels and a lower risk of cardiovascular disease, after accounting for body weight, compared to noncarriers. After a high-fat meal, the postprandial rise in triglyceride-rich lipoproteins and metabolomic markers of fatty acid oxidation were reduced in people with MC4R deficiency compared to controls, changes that favor triglyceride storage in adipose tissue. We concluded that central MC4Rs regulate lipid metabolism and cardiovascular disease risk in humans, highlighting potential therapeutic approaches for cardiovascular risk reduction.